The risk of early GFR decline in T1D patients with MA is associated with elevated concentrations of several urinary chemokines, such as IL-6, IL-8, MCP-1(CCL2), IP-10 (CXCL10) and MIP-1δ (CCL15) [5]. This evidence concerns the gene CXCL10 and type 1 diabetes mellitus.